Peptide Purity, Identity and Sterility Are Three Different Claims
Why a peptide purity percentage cannot answer identity or sterility questions, and what evidence belongs to each quality claim.
In brief
Purity, identity and sterility answer different questions. Chromatographic purity estimates the relative detected components under a method. Identity testing asks whether the target substance is what it claims to be. Sterility testing looks for viable microorganisms under a defined procedure. Passing one does not mean the other two passed—and none establishes clinical safety or efficacy.
What is established—and what is not
- Purity
- Relative detected composition under an analytical method
- Identity
- Evidence that the expected molecule is present
- Sterility
- Separate microbiological test with its own sampling limits
- Key uncertainty
- A report may omit concentration, endotoxin, stability or chain of custody
Five points to keep
- A large main peak does not prove the peak is the expected molecule.
- A matching mass does not quantify every possible impurity.
- Sterility is not visible and cannot be inferred from a sealed vial.
- Endotoxin and sterility are also different questions.
- Clinical safety remains outside the scope of an analytical release report.
Purity asks “what else is detected?”
Chromatographic purity usually compares the main detected peak with other detected peaks under defined conditions. Integration choices, detector response and method limitations shape the result.
It is useful analytical evidence, but it is not a universal percentage of everything inside the container.
Identity asks “is this the expected compound?”
Mass spectrometry, spectroscopy, sequencing or other orthogonal methods can support identity. The suitable method depends on the molecule and material.
A report is stronger when expected and observed results are shown, not merely the word “conforms.”
Sterility asks a microbiological question
Sterility testing uses defined culture conditions and sampling. It does not emerge from HPLC or LC-MS, and a clear solution can still be contaminated.
Testing also samples a finite portion of a batch, which is why manufacturing controls and container integrity remain important.
Endotoxin is not sterility
Bacterial endotoxin can remain even where living bacteria are not detected. An endotoxin test therefore answers another distinct question and requires a stated method and limit.
Build a claim-to-test map
For every quality claim, ask which test directly addresses it, whether the method was validated, which batch was sampled and what acceptance criterion applied. If the evidence does not map to the claim, the claim is not established.
Common questions, careful answers
Can HPLC prove sterility?
No. Sterility requires a separate microbiological test.
Can LC-MS prove purity?
It contributes molecular information, but purity assessment requires appropriate quantitative or comparative methods and context.
Does a sterile product automatically have low endotoxin?
No. Sterility and endotoxin are separate attributes and tests.
Evidence, standards and regulatory sources
- Q2(R2) Validation of Analytical Procedures ↗U.S. Food and Drug Administration
- Q6A Specifications: Test Procedures and Acceptance Criteria ↗U.S. Food and Drug Administration
- USP harmonized sterility test standard ↗United States Pharmacopeia
- Pyrogen and endotoxins testing: questions and answers ↗U.S. Food and Drug Administration
Continue the evidence trail.
Related guides deepen the distinction between mechanism, analytical quality, approval and human evidence.